The Vox Markets Podcast

Clem Chambers, British entrepreneur, market commentator and founder of ADVFN, joins Zak for a lively tour of market crashes, day trading and the blurred line between investing and gambling. They explore index saving, contrarian psychology, Level 2 data, spotting short positions and focusing on fewer stocks. IG Group’s marketing troubles, Monaco plans and tax residency round out the conversation.

Paul Scott, a UK small-cap analyst and markets commentator, joins Paul Hill to examine 23 stock ideas. They explore bargain valuations, cybersecurity specialists, nuclear engineering, software platforms, healthcare, fintech and consumer brands. Standouts include Hollywood Bowl, Venture Life, Avingtrans and Alfa Financial, while Plexus, Next 15 and XP Factory raise concerns over execution, leverage and scale.

Ian McDonough, CEO and Executive Chair of Blackbird plc, develops cloud-native video editing technology. He discusses elevate.io’s inclusion in Google’s Chromebook Perks programme, the rigorous year-long process behind the partnership, and why Google’s endorsement matters. He also explores elevate.io’s professional browser-based editing proposition, its market differentiation, and plans to expand visibility and adoption.

Michael Kraftman, CEO of Molecule Group, and Keith Butcher, its CFO, discuss the rebrand from Vulcan Two and plans for a regulated UK ePharmacy. They explore direct-to-consumer weight-loss treatments, acquisitions, warehouse and system integration, new healthcare categories, B2B growth, recurring revenue, and the market’s reaction to recent account closures.

Tony Hamilton, chief executive of Australian exploration company Georgina Energy, discusses the push toward drilling at Hussar, where flooding has delayed a 3,200-metre gas exploration program. He also covers seismic work assessing the field’s scale, preparations at Mount Winter, permit and acquisition progress, and the longer-term potential for helium, hydrogen, and natural gas production.

Paul Scott, a UK equity analyst and small-cap specialist, joins Paul Hur to examine 17 UK stock ideas. They discuss fresh buys in Bango and Brave Bison, IG Group’s trading shock, Saga’s cruise recovery, Tribal’s takeover battle, and Vesuvius uncertainty. Other highlights include defence momentum at MS International and TT Electronics, hidden value at Springfield Properties, and risks facing Tortilla, Capita and Avation.

Nick Rastall, Portfolio Director of Resourcing Tomorrow, previews Europe’s major mining gathering in London. He discusses renewed investor interest, record exhibitor demand, and the return of governments and global mining leaders. Hear about pitch battles, keynote sessions, leadership roundtables, networking that sparks deals, and the event’s awards dinner.

Ivan Murphy, co-founder and president of 1947 Oil & Gas, discusses the company’s AIM listing and its Gulf of America production portfolio. He covers the firm’s debt-free balance sheet, plans to extend mature assets, and ambitions to unlock around 20 million barrels of reserves. The conversation also explores acquisitions, seismic work, production upgrades, and building a cash-generating US oil business.

Steve McQuillan, Avingtrans CEO; Austin Adams, COO; and Stephen King, CFO, discuss a standout FY26 performance. They explore surging demand from nuclear, data centres, defence and infrastructure, plus a heavily oversubscribed £21m placing funding US expansion. Topics include potential business exits, Adaptix’s commercial progress, Magnetica’s strategy review, quantum and fusion opportunities, and the FY27 outlook.

Jeremy Skillington, CEO of clinical-stage biopharma Poolbeg Pharma, discusses the company’s latest progress. Topics include POLB001 entering patient trials for myeloma, new patents and FDA feedback, scientific advisers, and strong conference interest. He also covers a £3.5 million fundraise extending the runway to 2028, upcoming clinical milestones, and Poolbeg’s planned oral GLP-1 program.